β-Interferon-induced nephrotic syndrome in a patient with multiple sclerosis [1]

Clinical Nephrology

Volumn 54, Issue 5, 2000, Pages 425-426

  Gotsman, I ^a   Elhallel Darnitski, M ^a   Friedlander, Z ^a   Haviv, Y S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DIGOXIN;

ADULT; ANKLE EDEMA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; KIDNEY BIOPSY; LETTER; MULTIPLE SCLEROSIS; NEPHROTIC SYNDROME; PROTEINURIA; TREATMENT OUTCOME;

FEMALE; HUMANS; INTERFERON-BETA; MIDDLE AGED; MULTIPLE SCLEROSIS; NEPHROTIC SYNDROME;

EID: 0033761270     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Nephrotic syndrome complicating treatment with interferon alpha
2. Placebo-controlled multicentre randomized trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
3. Unusual glomerular lesion in a patient receiving long-term interferon alpha
4. Side-effect profile and adgerance to in the treatment of multiple sclerosis with interferon-1a
5. Phase I/II trial of human recombinant β-interferon serine in patients with renal cell carcinoma
6. Impact of interferon β-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
7. A case of nephrotic syndrome developing during postoperative gamma interferon therapy from renal cell carcinoma
8. Focal segmental glomerulosclerosis with acute renal failure associated with alpha interferon therapy